Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Directory
Corporate Governance
Pipeline
Background - FAK
Background - Fibrotic Cancers
Background - Fibrosis
Our FAK Inhibitors
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Research Reports
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Annual Reports
Half Yearly Reports
Quarterly Reports
Contact Us
Contact Us
Email Alerts
Investor Information
Home
>
Investor Information
>
US Shareholders
Welcome
Investor Fact Sheet
Investor Presentations
Research Reports
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
US Shareholders
8-Jul-2019
Annual Information Sheet - Year Ended 31 March 2019
15-Aug-2018
Annual Information Sheet - Year Ended 31 March 2018
6-Jul-2018
Annual Information Sheet - Year Ended 31 March 2017
29-May-2018
Annual Information Sheet - Year Ended 31 March 2016
